Goldman Sachs Maintains Neutral on Organon, Raises Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Chris Shibutani has maintained a Neutral rating on Organon (NYSE:OGN) and increased the price target from $18 to $20.

May 06, 2024 | 3:27 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Goldman Sachs maintains a Neutral stance on Organon but raises the price target from $18 to $20.
The adjustment in price target by Goldman Sachs suggests a positive outlook on the stock's value, albeit the Neutral rating indicates that the firm does not see significant upside or downside in the near term. This could lead to a stable short-term performance for OGN, as the market digests the implications of the revised price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100